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ABSTRACT: The process known as “adaptive response” allows
Escherichia coli to respond to small doses of DNA-methylating
agents by upregulating the expression of four proteins. While the
role of three of these proteins in mitigating DNA damage is well
understood, the function of AidB is less clear. Although AidB is a
flavoprotein, no catalytic role has been established for the bound
cofactor. Here we investigate the possibility that flavin plays a
structural role in the assembly of the AidB tetramer. We report the
generation and biophysical characterization of deflavinated AidB
and of an AidB mutant that has greatly reduced affinity for flavin
adenine dinucleotide (FAD). Using fluorescence quenching and analytical ultracentrifugation, we find that apo AidB has a high
affinity for FAD, as indicated by an apparent dissociation constant of 402.1 ± 35.1 nM, and that binding of substoichiometric
amounts of FAD triggers a transition in the AidB oligomeric state. In particular, deflavinated AidB is dimeric, whereas the
addition of FAD yields a tetramer. We further investigate the dimerization and tetramerization interfaces of AidB by determining
a 2.8 Å resolution crystal structure in space group P32 that contains three intact tetramers in the asymmetric unit. Taken together,
our findings provide strong evidence that FAD plays a structural role in the formation of tetrameric AidB.
E
xposure of Escherichia coli cells to small doses of DNA-
methylating agents initiates a response that mitigates the
mutagenic and cytotoxic effects of DNA methylation.
1−3 This
process, known as the adaptive response, involves the
upregulation of four proteins: Ada, AlkA, AlkB, and AidB.
1,4
Ada is a DNA methyltransferase that irreversibly transfers a
methyl group from the DNA phosphodiester backbone to its
Cys38 side chain or from O4-methyl-T and O6-methyl-G
lesions to its Cys321 side chain.
5,6 Upon methylation at Cys38,
Ada becomes a transcription factor and activates the tran-
scription of its own encoding gene and the other adaptive
response genes.
7,8 AlkA is a DNA glycosylase that repairs a
variety of lesions, including 3-methyl-A, through a base excision
mechanism.
9,10 The third member of the adaptive response,
AlkB, is an α-ketoglutarate- and Fe(II)-dependent dioxygenase
that repairs 1-methyl-A and 3-methyl-C lesions by an oxidative
demethylation mechanism.
11−15 While the roles of Ada, AlkA,
and AlkB in the adaptive response are well-established, AidB is
still enigmatic.
Although reported to diminish the mutagenic effect of the
methylating agent N-methyl-N′-nitro-N-nitrosoguanidine
(MNNG),
16 an exact AidB phenotype has been difficult to
establish. While in vitro studies clearly show protection of DNA
from methylating agents such as MNNG,
17 cells with an
inactivated aidB gene do not show the expected increase in
methylation sensitivity.
2,18 Recently, it has been suggested that
localization of AidB and its protective function to specific
regions of the genome could obscure the AidB phenotype,
although more work is needed to fully resolve this issue.
17 Our
understanding of how AidB exerts its protective function is also
in its infancy. AidB is known to be a flavin adenine dinucleotide
(FAD)-containing protein
19 that shares sequence homology
with members of the acyl-coenzyme A dehydrogenase (ACAD)
flavoenzyme family and exhibits low levels of isovaleryl-
coenzyme A dehydrogenase (IVD) activity.
16 However, this
activity is 1000-fold lower than that of other known ACADs,
indicating that it does not represent the biological function of
AidB.
19 The concomitant discovery that AidB can bind double-
stranded DNA nonspecifically with low micromolar dissocia-
tion constants
19,20 led to a functional model in which AidB
screens DNA and directly repairs methylated bases by a
dehydrogenation reaction.
19 While there is structural and
biochemical support for the presence of DNA-binding domains
on AidB,
19,20 the AidB structure also shows that the four FAD
binding sites per tetramer are far from these DNA-binding
regions, raising doubt that AidB directly repairs DNA.
20
In a previous crystallographic study, AidB was crystallized in
the presence of DNA oligonucleotides, and although these
DNA molecules were not observed in the crystal structure, the
assembly of AidB molecules in the crystal lattice created 25 Å
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20 On the
basis of this structure, a model was put forward in which AidB
sheaths DNA from destructive modification by completely
sequestering it in these pores, with a potential secondary role
for the FAD cofactor in detoxifying damaging agents via an
unknown mechanism.
20 It was later shown that AidB can bind
to certain DNA sequences with enhanced affinity during
normal cell growth, including the upstream sequence of its own
promoter, and that AidB plays a protective role even when its
DNA-binding regions are deleted, suggesting that the purpose
of the DNA binding ability of AidB is to localize detoxification
activity rather than to protect DNA by providing a sheath.
21
Again, the exact nature of this putative detoxification reaction is
unknown, with a recent study ruling out MNNG as an obvious
substrate candidate.
22
As outlined above, numerous models have been proposed for
the role of AidB in the adaptive response. At the heart of this
mystery is the role of the bound FAD. Is AidB an enzyme that
uses the FAD as a cofactor for detoxification or DNA repair? Is
AidB a DNA-binding protein for which the FAD plays a
structural role, or could FAD play both a catalytic and a
structural role in a multifaceted AidB protein? To address these
questions, we investigated for the first time the properties of
binding of FAD to AidB. Using a combination of techniques,
we find that FAD binds tightly and cooperatively to AidB,
inducing a change in the oligomeric state of the protein, from
dimer to tetramer.
■ MATERIALS AND METHODS
Cloning and Site-Directed Mutagenesis. The AidB
gene was amplified from E. coli strain AB1157 using a protocol
reported previously.
19 The amplified gene was subcloned into a
pET28a vector (Novagen) that had been digested with NcoI
and HindIII. The resulting tag-free construct, pET28a-wtAidB,
was transformed into E. coli BL21(DE3) cells for expression.
An AidB triple mutant (T185V/S191R/R324D, mtAidB) was
generated from the wild-type AidB-pET28a clone using the
QuikChange Site-Directed Mutagenesis Kit (Stratagene) and
the primers listed in Table S1 (Supporting Information).
Overexpression and Purification. Luria-Bertani medium
(4 × 1 L) containing 50 μg/mL kanamycin was inoculated with
a starter culture of E. coli BL21(DE3) transformed with
pET28a-wtAidB. Cells were grown at 37 °C to an optical
density of 0.5 at 600 nm, at which point the cells were induced
with 1 mM isopropyl β-D-1-thiogalactopyranoside. The cultures
were then transferred to 21 °C for overnight growth. Cells were
harvested by centrifugation at 10000g for 10 min, and the
resulting cell pellets were resuspended in AidB buffer [50 mM
Tris (pH 7.8), 1 mM ethylenediaminetetraacetic acid (EDTA),
300 mM NaCl, 10% (v/v) glycerol, and 5 mM β-
mercaptoethanol (β-ME)] and lysed by sonication. Cell debris
was separated from the soluble supernatant by centrifugation at
35000g for 30 min at 4 °C. The cell lysate was treated with
ammonium sulfate at final concentrations of 30 and 45% in a
stepwise fashion. After each addition, the solution was stirred
gently for 1 h at room temperature to reach equilibrium.
Precipitated protein was removed by centrifugation at 6000g for
30 min at 4 °C. The protein that precipitated after the addition
of 45% ammonium sulfate was separated from the supernatant
and dissolved in 10 mL of AidB buffer. This solution,
containing crude wtAidB, was loaded onto a low-substitution
phenyl Sepharose column (GE Healthcare) pre-equilibrated
with AidB buffer, and the column was washed with 10 column
volumes of AidB buffer. wtAidB was eluted with AidB buffer
supplemented with 0.4% (w/v) deoxycholate. Fractions
containing wtAidB, as judged by color and sodium dodecyl
sulfate−polyacrylamide gel electrophoresis (SDS−PAGE),
were merged, concentrated to 5 mL, and loaded onto a HiPrep
26/60 Sephacryl S200 size exclusion column (Amersham
Bioscience) pre-equilibrated with AidB buffer. Protein was
eluted with 1.5 column volumes of AidB buffer. Fractions
containing pure wtAidB, as judged by SDS−PAGE, were
merged and used for experiments within 2 days (here, “fresh”
AidB is protein that is <2 days old). mtAidB was overexpressed
and purified in the same fashion as wtAidB. Reduced wtAidB
was generated by incubation of a solution of 1 mg/mL wtAidB
in AidB buffer with a 2-fold molar excess of sodium dithionite
in an oxygen-free environment (Coy Scientific chamber under a
95% Ar/5% H2 atmosphere).
Deflavination. wtAidB (10 mL) that eluted from the
Sephacryl S200 size exclusion column was diluted to a final
volume of 50 mL with deflavination buffer [250 mM sodium
phosphate (pH 7.5), 3 M KBr, 1 mM EDTA, 10% (v/v)
glycerol, and 5 mM β-ME]. The mixture was incubated at 4 °C
for 4 days, concentrated to 5 mL, and applied to a PD-10
desalting column (GE Healthcare) pre-equilibrated with
deflavination buffer to remove free FAD. The amount of
residual FAD was determined photometrically by the
absorbance at 450 nm (ε 450 = 11300 M−1 cm−1 19), and the
deflavination process was repeated if necessary. The final apo
wtAidB sample was buffer exchanged with AidB buffer using a
PD-10 column. UV−vis spectra of apo wtAidB were recorded
on a Cary 50 Bio spectrophotometer (Varian).
Circular Dichroism Spectroscopy. Circular dichroism
spectra were recorded on an Aviv 62 DS circular dichroism
spectrometer at 25 °C using a 0.1 cm optical path length cell.
The protein concentration was 1.2 mg/mL in a buffer
containing 200 mM potassium phosphate (pH 7.5), 1 mM
EDTA, 10% (v/v) glycerol, and 5 mM β-ME. Ellipticity was
recorded from 200 to 240 nm in 1 nm steps with a 20 s
averaging time and a 1.5 nm bandwidth. At least three scans
were averaged for each sample. Mean residue ellipticity, θ in
degrees square centimeters per decimole, was calculated from
the equation θ = MRW × θobs/(10dc), where θobs is the
observed ellipticity measured in degrees, MRW is the mean
residue molecular mass (112.0 Da), c is the protein
concentration in grams per milliliter, and d is the optical path
length of the cell in centimeters.
23
Fluorescence Quenching. The affinity of apo wtAidB for
free FAD was determined by monitoring the extent of
fluorescence quenching
24 at 20 °C, using a SpectraMax M2
microplate reader (Molecular Devices). Fluorescence emission
of FAD was detected at 520 nm with excitation at 350 nm.
Fresh apo wtAidB (200 nM to 5 μM) and 1 μM FAD, each in
AidB buffer, were mixed by being shaken for 2 min.
Fluorescence was recorded over time until equilibrium was
reached. The change in fluorescence intensity as a function of
binding of apo wtAidB to FAD was fit to the Hill equation
(eq 1), which accounts for cooperative binding:
(1)
where ΔF is the change in FAD fluorescence at 520 nm at each
AidB concentration, ΔFmax is the change in fluorescence at 520
nm at a saturating wtAidB concentration, Kd is the dissociation
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concentration of wtAidB.
Analytical Ultracentrifugation. Sedimentation velocity
experiments were performed using a Beckman Coulter Optima
XL-I analytical ultracentrifuge equipped with a Beckman
An60Ti rotor and an XL-A monochromator. Absorbance data
were collected at 280, 350, or 385 nm, 20 °C, and 30000 rpm
until sedimentation was complete. All experiments were
performed with at least two different protein samples. The
protein concentrations for the different samples were 9.0 and
9.6 μM for holo wtAidB, 6.1 and 16.7 μM for apo wtAidB, 7.0
and 8.5 μM for apo mtAidB, 6.8 and 16.7 μM for reconstituted
wtAidB, and 7.4 and 7.4 μM for reduced wtAidB. All protein
samples were freshly prepared in AidB buffer. For reduced
wtAidB, the protein solution and the analytical ultracentrifuga-
tion cells were handled in an oxygen-free environment (Coy
Scientific chamber under a 95% Ar/5% H2 atmosphere) until
the cells were sealed from air. Stoichiometric reconstitution
experiments were performed by incubation of apo wtAidB with
free FAD at 4 °C for 16 h. For the following sedimentation
velocity experiments, the FAD absorbance at 385 nm was
simultaneously monitored along with the absorbance at 280
nm. The density and viscosity of the buffer solution at 20 °C
were calculated with Sednterp, which uses formulae based on a
database of known values.
25 Hydropro was used to calculate
theoretical AidB hydrodynamic properties,
26 based on a
hydrodynamic model created from our AidB crystal structure.
The distribution of sedimentation coefficients was calculated by
fitting sedimentation velocity data using Sedfit.
27 For this
analysis, the continuous distribution c(s) Lamm equation model
was used, which accounts for protein diffusion.
27 All Sedfit
sedimentation coefficient results were confirmed by additional
g*(s) analysis using DCDT+.
28
Fluorescence Anisotropy. Fluorescence anisotropy ex-
periments were performed using a SpectraMax M5 microplate
reader (Molecular Devices) as described previously.
20 The
oligonucleotide consisted of a 28-mer of DNA that is known to
bind to AidB (UP element with the −35 box of the rrnB P1
promoter) and contained a fluorescein label at the 5′-end: 5′-
fluorescein-GAAAATTATTTTAAATTTCCTCTTGTCA-3′
and 5′-TGACAAGAGGAAATTTAAAATAATTTTC-3′.
17
Polarized fluorescence was monitored using excitation and
emission wavelengths of 495 and 538 nm, respectively. Samples
of 50 nM fluorescein-labeled DNA in AidB buffer were mixed
with 0−20 μM holo or apo wtAidB or apo mtAidB, in
agreement with conditions used previously.
20 Anisotropy was
measured after equilibrium was reached. Binding curves were fit
to a two-state binding model to determine Kd as follows:
(2)
where r0 is the anisotropy of labeled DNA, rmax is the anisotropy
at saturating concentrations of AidB, Kd is the dissociation
constant, and [AidB] is the concentration of AidB.
Crystallization of AidB and Data Collection in the P32
Crystal Form. wtAidB was crystallized at 25 °C by the
hanging drop vapor diffusion technique; 1 μL of a protein
solution [10 mg/mL wtAidB in 10 mM Tris (pH 7.8), 100 mM
NaCl, 10% (v/v) glycerol, and 2 mM β-ME] was mixed with 1
μL of a precipitant solution [100 mM HEPES (pH 7.5), 20%
(v/v) ethanol, and 200 mM MgCl2] on a coverslip and sealed
over 0.5 mL of precipitant solution. Trigonal crystals with
dimensions of ∼0.3 mm × 0.2 mm × 0.1 mm appeared within 2
weeks. Crystals were flash-frozen in liquid nitrogen without the
use of additional cryoprotectants.
All crystals belonged to space group P32. Data were collected
to 2.8 Å resolution at the Advanced Photon Source (Argonne,
IL) on beamline 24ID-C using an ADSC Q315 detector. All
data were collected at 100 K. Data were reduced in Denzo and
scaled using Scalepack.
29 Data collection statistics are
summarized in Table S2 of the Supporting Information.
Determination and Refinement of the P32 Crystal
Structure of AidB. The structure of wtAidB was determined
by molecular replacement in Phaser
30 using data to 2.8 Å
resolution. The search model was the published structure of
wtAidB (Protein Data Bank entry 3DJL
20) without any cofactor
or water atoms. The best rotational and translational solution
had a correlation coefficient of 26.9 with 12 wtAidB protomers
per asymmetric unit, corresponding to three tetramer units
related by noncrystallographic symmetry (NCS). The resulting
model was subjected to rigid body refinement followed by
simulated annealing refinement in CNS.
31,32 After the first
round of refinement, Rcryst and Rfree were 31.9 and 31.5%,
respectively. Cofactors, ions, and a modest number of water
molecules were added to the model at 2.8 Å resolution followed
by iterative rounds of model building in Coot
33 and refinement
in PHENIX.
34 NCS restraints were applied across the six
wtAidB dimers in the asymmetric unit to reduce the number of
variables in the refinement as opposed to applying NCS
restraints across wtAidB tetramers. Residues involved in crystal
lattice contacts were excluded from NCS restraints. The final
cycles of refinement included TLS parametrization using one
TLS group per tetramer.
35 In all chains, either residues 2−540
or residues 1−540 were observed out of a total of 541 residues.
In addition, each chain contained one molecule of FAD, one
chloride ion, and a disulfide bridge between Cys28 and Cys540.
Simulated annealing composite omit maps calculated in CNS
were used to validate the model.
31,32 The final structure was
refined to 2.8 Å resolution with Rcryst and Rfree values of 20.4
and 22.9%, respectively. The resulting model exhibited
excellent stereochemistry and small root-mean-square devia-
tions from ideal values for bond lengths and bond angles; 0.1%
of the residues are in disallowed regions of the Ramachandran
plot. For most of the outliers, the backbone is involved in FAD
binding, possibly providing stabilization for less favorable
backbone conformations. Refinement statistics for the final
model are summarized in Table S3 of the Supporting
Information. The geometry of the final model was analyzed
using MolProbity.
36 Figures were generated in PyMOL.
37
■ RESULTS
Preparation and Spectroscopic Analysis of Deflavi-
nated AidB. To investigate the role of the bound flavin
cofactor, we generated deflavinated AidB (apo AidB) both by a
chemical method using KBr (apo wtAidB) and by creating a
flavin-binding deficient triple mutant (T185V/S191R/R324D)
of AidB (apo mtAidB). Whereas deflavination by typical
treatments, such as dialysis and chromatography,
38 was
unsuccessful with AidB, dilution of fresh wtAidB into a buffer
containing KBr, a chaotropic agent that competes with the
flavin for the phosphate binding site, quantitatively yielded apo
wtAidB. To generate a mutant form of AidB with greatly
reduced FAD affinity, we inserted the T185V, S191R, and
R324D mutations into the sequence of wtAidB. All three of
these residues are directly involved in FAD binding (Figure S1
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chromatography step of the protein purification procedure, the
resulting triple mutant mtAidB eluted as two species. A minor
species with a shorter retention time exhibited a bright yellow
color, indicative of bound FAD, while the major species was
colorless and appeared to be deflavinated. Because we did not
overexpress our mutant protein in an aidB knockout strain, the
minor species most likely represents endogenous AidB while
the major species is our overexpressed mutant protein.
To ensure deflavination of all samples used in these
experiments, we analyzed both apo wtAidB and apo mtAidB
by UV−vis spectroscopy. The characteristic FAD absorption
features were not observed in either apo wtAidB or apo mtAidB,
indicating that no or very little FAD was present in either
sample (Figure S2A of the Supporting Information). We then
performed circular dichroism (CD) spectroscopy on holo
wtAidB, apo wtAidB, and apo mtAidB to assess whether the
deflavinated protein was properly folded. The CD spectra of
apo wtAidB and apo mtAidB were almost identical to that of
holo wtAidB, with no deviations above background (Figure S2B
of the Supporting Information). Upon stoichiometric recon-
stitution of apo wtAidB with FAD, the absorption features were
restored and the CD spectrum remained unchanged. Therefore,
we concluded that we achieved deflavination without major
structural perturbations and used these deflavinated species for
further analyses.
wtAidB Binds FAD Tightly and Cooperatively. To
investigate the interaction of FAD with wtAidB, we measured
the dissociation constant (Kd) by fluorescence quenching
(Figure 1). FAD has a fluorescence emission band centered at
520 nm when it is excited at 350 nm. When FAD binds to
wtAidB, the fluorescence emission of FAD at 520 nm is
quenched by a factor of 3.1. Binding data were fit to a Hill
equation (eq 1) to account for cooperative binding. Because
cooperativity implies multiple and unequal binding equilibrium
states, the resulting Kd is a rough estimation of the average
dissociation constant. We calculate an apparent Kd of 402.1 ±
35.1 nM with a Hill coefficient (h) that is greater than 1 (1.73
± 0.21), consistent with tight and cooperative binding of FAD
to wtAidB.
The Oligomeric State of AidB Is Flavin-Dependent. We
performed sedimentation velocity analytical ultracentrifugation
(AUC) experiments to determine the oligomeric state of
AidB under different conditions. Sedimentation velocity data
were fit to a continuous distribution c(s) Lamm equation model
using Sedfit,
27 yielding the experimental sedimentation
coefficient distribution. All sedimentation coefficients, which
are dependent on the mass and shape of the protein, were
normalized to 20 °C in water (s20,w). We also used Hydropro
28 to
determine theoretical s20,w values for different oligomers of AidB
based on our crystal structure (see below). The calculated s20,w
value for the putative AidB tetramer was 11.5 S. In contrast, the
s20,w values for possible dimer combinations ranged between 6.4
and 7.0 S, and the s20,w value for an AidB monomer was 4.2 S.
These values were compared to experimentally determined s20,w
values, allowing us to assign oligomeric states to the different
AidB samples.
First, we collected AUC data on holo wtAidB, apo wtAidB,
and apo mtAidB to assess the influence of the FAD cofactor on
the oligomeric state. For holo wtAidB, we obtained an
experimental s20,w value of 11.5 S (Figure 2A), indicative of a
tetramer structure and in agreement with previously reported
results.
19,20 Trace amounts of smaller species (asterisks in Figure
2A) likely represent a small amount of misfolded, denatured, or
monomeric protein. In contrast, the major species of apo wtAidB
exhibited an s20,w value of 7.0 S, indicating that apo wtAidB is a
dimer (Figure 2B). Small amounts of a tetrameric species are
observed in the sample, but the ratio of dimer to tetramer did not
change with a 2.7-fold increase in protein concentration. For apo
mtAidB, we obtained an s20,w value of 7.1 S for the dominant
species (Figure 2C), in close agreement with the value obtained
for apo wtAidB. Thus, both deflavinated AidB species are dimeric
in solution, indicating that AidB undergoes a change in the
oligomerization state, from a tetramer to a dimer, upon removal
of the FAD cofactor.
Using a stepwise reconstitution protocol of apo wtAidB with
free FAD, we then tested whether the observed changes in
oligomerization state are reversible. FAD was added to apo
wtAidB at molar ratios of 0.25, 0.5, and 1.0 with respect to the
concentration of the AidB monomer. The samples were then
subjected to AUC with simultaneous monitoring of the
absorbance at both 280 and 385 nm (Figure 2D−F).
Sedimentation coefficients of the various forms of AidB were
calculated from the absorbance at 280 nm (Figure 2D-F, top
traces), while the absorbance at 385 nm was used to identify
FAD-containing AidB (Figure 2D-F, bottom traces). Upon
reconstitution of apo wtAidB with 0.25 equiv of FAD, we
observed a species with an s20,w value of 11.5 S in the AUC
experiment, accounting for 47% of the total AidB (Figure 2D).
A second species exhibited an s20,w value of 7.0 S, accounting for
the remaining AidB. The absorbance at 385 nm was observed
only in the species with an s20,w value of 11.5 S. Thus, 47% of
the AidB in solution had formed a tetramer, and all FAD was
bound to this tetrameric species; no FAD was bound to a
dimeric species that was also present in solution. When we
increased the amount of FAD to 0.5 equiv relative to the
concentration of AidB monomer, 77% of AidB was present in a
tetrameric state. Again, FAD was only observed in those
tetramers (Figure 2E). Finally, reconstitution using 1 equiv of
FAD relative to AidB monomer resulted in 95% tetramer
formation, a value similar to that observed for holo wtAidB
(Figure 2F). All in all, these results suggest the presence of an
FAD-dependent equilibrium between the dimeric and tetra-
meric states of AidB in which binding of FAD induces a
transition to the tetramer.
Figure 1. Quenching of FAD fluorescence upon binding to apo
wtAidB. Plotted is the ratio between the change in FAD fluorescence
at each wtAidB concentration (ΔF) and the change in fluorescence at
saturating wtAidB concentrations (ΔFmax) vs the concentration of
wtAidB. The data were fit to the Hill equation (eq 1). Data points and
error bars represent the average of three experiments.
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cofactor had an effect on the oligomeric state of wtAidB. We
generated wtAidB in complex with its reduced flavin cofactor by
chemical reduction of holo wtAidB with a 2-fold molar excess of
sodium dithionite in an oxygen-free environment. Reduced
wtAidB exhibited an s20,w value of 11.2 S (Figure 2G), indicating
that reduced wtAidB is a tetramer. We confirmed that the flavin
cofactor remains in the reduced state during the time course of
an AUC experiment by collecting UV−vis spectra in an oxygen-
free environment after the experiment, which indicated the
absence of the oxidized flavin cofactor in the sample (data not
shown). Furthermore, we monitored the absorbances at 280,
350, and 385 nm in a separate anaerobic AUC experiment.
All three traces exhibited the same profile: the absorbances
at 350 and 385 nm remained the same over the time course of
the experiment, indicating that there was no change in the
oxidation state of the cofactor (data not shown). Thus, while
removal of the flavin cofactor has a significant impact on the
oligomerization state of wtAidB, holo wtAidB is a tetramer
regardless of the oxidation state of the flavin cofactor.
Interaction between DNA and Apo AidB. To estimate
the effect of deflavination on the DNA binding capability of
wtAidB, we measured the affinity of holo wtAidB, apo wtAidB,
and apo mtAidB for DNA by fluorescence anisotropy. In our
binding studies, a specific E. coli DNA fragment (5′-
GAAAATTATTTTAAATTTCCTCTTGTCA-3′) was chosen
because AidB offers enhanced protection from damage to this
DNA sequence.
17 We first determined the Kd of this
oligonucleotide and holo wtAidB to be 2.2 ± 0.1 μM under
conditions similar to those used previously (data not shown).
20
This interaction is approximately 2-fold stronger than the
interaction between holo wtAidB and a fluorescein-tagged
random 25-mer of DNA used in previous experiments (Kd =
4.3 ± 0.1 μM).
20 We also measured the effect of ionic strength
on AidB−DNA affinity by lowering the NaCl concentration
from 300 to 100 mM. As expected, tighter binding (Kd = 463 ±
48 nM) between holo wtAidB and DNA is observed at the
lower salt concentration (Figure 3). Under these low-salt
conditions, both forms of apo AidB have similar though
nonidentical DNA affinities compared to each other and to
holo wtAidB. The Kd for the interaction of apo mtAidB and
DNA is 763 ± 66 nM, and the Kd for the interaction of apo
wtAidB and DNA is 548 ± 20 nM (Figure 3). Thus, although
Figure 2. Sedimentation coefficient distributions for different AidB samples, showing the effect of FAD on AidB oligomeric state: (A) holo wtAidB,
(B) apo wtAidB, (C) apo mtAidB, (D) apo wtAidB reconstituted with 0.25 equiv of free FAD, (E) apo wtAidB reconstituted with 0.5 equiv of free
FAD, (F) apo wtAidB reconstituted with 1.0 equiv of free FAD, and (G) reduced holo wtAidB. For panels D−F, the distribution in the top panel is
calculated from 280 nm absorbance and the distribution in the bottom from the FAD absorbance at 385 nm. Minor species observed (marked with
asterisks) are likely the result of misfolded, denatured, or monomeric protein.
Figure 3. Interaction between a fluorescein-labeled DNA 28-mer and
holo wtAidB (■), apo wtAidB (○), and apo mtAidB (●). Δr is the
change in fluorescence anisotropy observed upon addition of AidB.
Dotted lines are the curve fits according to eq 2. Data points and error
bars represent the average of three experiments.
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deflavination of AidB, we find the effect on DNA binding to be
negligible.
P32 Crystal Structure of the AidB Tetramer. To
investigate the molecular basis of the FAD-dependent changes
in the AidB oligomerization state, we determined the crystal
structure of holo wtAidB in space group P32 to 2.8 Å resolution
(Figure 4B−D). Unlike the previous I222 structure,
20 this
crystal form has three tetramers of AidB in the asymmetric unit
as opposed to a single monomer. The P32 structure was
determined by molecular replacement using the I222 crystal
structure.
20 Protomers from the two crystal structures super-
impose with a root-mean-square deviation (rmsd) of 0.34 Å
over 538 Cα atoms, indicating that the structures of wtAidB
protomers are unchanged. Also, the wtAidB tetramer from the
P32 structure and the AidB tetramer generated by symmetry
from the I222 structure superpose well, with an rmsd of 0.40 Å
over 2152 Cα atoms. However, there are profound differences
in the crystal packing arrangement of these tetramers (Figure
4A,B). The previous structure contained a crystal lattice in
which four AidB tetramers form another higher-order oligomer,
with the AidB DNA-binding regions lining a central pore with a
25 Å diameter (Figure 4A). In the P32 crystal structure, the
three tetramers in the asymmetric unit are arranged in a
triangular shape with the DNA-binding domains pointing
outward and no obvious pore (Figure 4B). Even when
considering symmetry-related molecules in the P32 crystal
lattice, the resulting arrangement does not reveal a central pore
with which AidB could sequester DNA (Figure S3 of the
Supporting Information). Thus, although the tetramer of AidB
is conserved in both crystal forms, the assembly of those
tetramers into higher-order oligomers is not.
Structural Basis for Flavin-Dependent Oligomeriza-
tion. In the P32 crystal structure, each protomer of an AidB
tetramer interacts with each of the other protomers. Thus, there
are three different types of dimers that could be formed upon
deflavination: “up and down” (AB or CD dimers), “side by
side” (AC or BD dimers), and “diagonal” (AD or BC dimers)
(Figure 5). To investigate which of the three possible dimers of
AidB is present after deflavination, we calculated theoretical s20,w
values for each of the dimers from our crystal structure and
compared these values to the results from our AUC experiments.
We obtained theoretical s20,w values of 7.0, 6.6, and 6.4 S for the
AB dimer, the AC dimer, and the AD dimer, respectively. These
values reflect their differences in shape, as the AB dimer would be
more globular while the AC and the AD dimers would be more
elongated (Figure 5). Our observed s20,w values for apo wtAidB
and apo mtAidB are 7.1 and 7.0 S, respectively, consistent with
the value calculated for the AB dimer of 7.0 S.
Figure 4. Crystal structures of holo wtAidB. (A) Higher-order oligomer of AidB observed in the I222 crystal structure,
20 with the central AidB
tetramer colored by protomer as described below. (B) Three AidB tetramers in the asymmetric unit of the P32 crystal structure, with the bottom
AidB tetramer colored by protomer. (C) Tetramer of holo wtAidB with protomers labeled A−D. (D) Tetramer of holo wtAidB, rotated by 45° with
respect to panel C. Ribbons are transparent to emphasize the bound FAD molecules and the L1′2′ loops of each protomer (thicker ribbons, marked
by arrows). The general coloring scheme was as follows: protomers in a tetramer colored yellow (A), orange (B), cyan (C), and blue (D). Additional
tetramers are colored pink. The putative DNA-binding regions of AidB are highlighted in purple and magenta. Bound FAD molecules are shown in
ball-and-stick representation with carbon atoms colored green.
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an extensive interface, burying a combined area of more than
6500 Å2 from solvent (Figure 5A). The dimer interface features
33 hydrogen bonds and 24 salt bridges. In contrast, the AC and
AD dimer interfaces have solvent-buried areas of only 1782 and
1319 Å2, respectively (Figure 5B,C), providing an additional
rationale for the presence of an AB dimer in solution. The FAD
of each protomer is bound at the AB dimer interface, with both
protomers contributing to the binding of FAD (Figure 6A).
FAD is bound by 12 hydrogen bonds from one protomer, while
the second protomer adds another two hydrogen bonds and
two salt bridges to binding of the pyrophosphate moiety and
the adenine ring (Figure 6A). In contrast, FAD makes no direct
contacts across the AC or AD interfaces.
The AidB tetramer, as observed in both crystal structures, is a
dimer of dimers with three 2-fold symmetry axes (Figure
4C,D). The combined buried surface area between the AB and
the CD dimers is 5700 Å2, and we refer to this interface as the
“tetramer interface”. With 37 hydrogen bonds and 10 salt
bridges at this interface, the size of the buried surface area
(7.3% of the total surface area) and the number of specific
stabilizing interactions are small compared to the overall size of
the putative assembly. When the tetramer interface is treated as
a single interface between two polypeptide chains, the
complexation significance score determined by the PISA server
for interface analysis
39 is extremely low, 0.086 on a scale from 0
(lowest significance) to 1 (highest significance). Furthermore,
the free enthalpy of formation is calculated to be 12.3 kcal/mol
for this interface, rendering interface formation energetically
unfavorable. These analyses would suggest that the interface is
not significant for complex formation and is instead an artifact
of crystal packing. Nonetheless, our AUC data provide
conclusive evidence that holo wtAidB is indeed a tetramer in
solution.
As described previously,
20 tetramer formation is mainly
mediated by the N-termini and the L1′2′ loops (residues 69−80)
Figure 5. Dimer interfaces within holo wtAidB: (A) AB dimer, (B) AC dimer, and (C) AD dimer of wtAidB shown as ribbons. Protomers A−D of
AidB are colored yellow, orange, blue, and cyan, respectively, with the DNA-binding regions colored magenta and purple. Bound FAD molecules are
shown in ball-and-stick representation with carbon atoms colored green. Calculated s20,w values are given for each dimer.
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assembly is symmetric, each set of interactions is present four
times at the interface. The L1′2′ loop of each protomer
protrudes into the opposite dimer interface, generating an
overall structure that resembles two gears interlocking (Figure 4D).
The residues of the four loops contribute the majority of inter-
actions as well as 31% of the buried surface area toward forma-
tion of the tetramer (Figure 6B). In addition, four chloride ions
are present at these interfaces in the P32 structure, one for each
L1′2′ loop. Each of these chloride ions is located between Arg71
Figure 6. Involvement of FAD and chloride at interfaces of holo wtAidB. (A) Wall-eyed stereoview of the bound FAD cofactor at the AB dimer
interface of AidB, with coloring as in Figure 4. Residues interacting directly with the FAD are shown as sticks, colored according to their
corresponding protomer. Hydrogen bonding and ionic interactions between the FAD cofactor and its corresponding protomer are represented as
black dashed lines, while interactions between the cofactor and the opposite protomer are represented as magenta dashed lines. Residues of the
opposite protomer are labeled with their protomer in parentheses. Side chains not involved in specific contacts have been truncated for the sake of
clarity. (B) Wall-eyed stereoview of the tetramer interface and the nearby FAD cofactor, with coloring as in Figure 4. Residues involved in
interactions at the interface are shown as sticks, colored and labeled according to their corresponding protomer. Water molecules are shown as red
spheres. Hydrogen bonding and ionic interactions are represented as black dashed lines. (C) Wall-eyed stereoview of chloride ions bound at the
tetramer interface, with coloring as in Figure 4. Chloride ions are shown as purple spheres. Interactions between chloride ions and protein atoms are
represented as black dashed lines. Residues are labeled with their corresponding protomer in parentheses.
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two adjacent positive charges (Figure 6C). The L1′2′ loops have
no direct interactions with the FAD cofactors. However, Ala74,
Gln75, Gly76, and Arg77 are positioned within 13 Å of the
FAD cofactor, and a network of hydrogen bonds connects these
residues to the pyrophosphate moiety and the isoalloxazine ring
system of the cofactor (Figure 6B).
■ DISCUSSION
The function of AidB in the adaptive response has been a
subject of debate.
16,17,19−21 With no catalytic activity reported
outside of the residual IVD activity, it remains unclear if the
role of AidB in the adaptive response involves the use of the
bound flavin in catalysis. The flavoprotein literature reports
several cases in which flavins play structural roles and are not
directly involved in catalysis.
40 Glyoxylate carboligases, for
example, do not appear to use their flavins to catalyze redox
chemistry but instead display flavin-dependent transitions in
the oligomerization state.
41,42 For both Pseudomonas oxalaticus
and E. coli glyoxylate carboligases, deflavination leads to
oligomer disassembly and subsequent inactivation.
41,42 With
this precedent in the literature, here we investigate the
possibility that FAD serves a structural role in AidB.
With the first crystal structure of AidB showing FAD bound
at the AB and the CD dimer interfaces,
20 it was tempting to
propose that FAD might play a structural role in the
dimerization. To test this idea, deflavinated AidB (apo AidB)
was generated to measure the FAD dissocation constant and to
investigate whether AidB is monomeric or even unfolded without
flavin. Using CD spectroscopy, we found that removal of flavin
does not unfold the protein (Figure S2B of the Supporting
Information), and by fluorescence quenching, we measured an
apparent Kd for FAD of 402.1 ± 35.1 nM and a Hill coefficient
(h) of 1.73 ± 0.21, consistent with each FAD making extensive
interactions with two AidB protomers. With the knowledge that
FAD binds tightly and cooperatively to AidB, along with crystal
structures showing FAD engaged in numerous interactions at the
AB dimer interface, AUC experiments were conducted to
determine if AidB is monomeric in the absence of flavin.
Surprisingly, we found that both apo wtAidB and apo mtAidB
exhibit a dimeric state instead of the expected monomeric state,
while holo wtAidB is a tetramer.
Because the AB interface is most directly affected by FAD
binding (Figures 5 and 6A), we considered whether the dimeric
structure of apo AidB could be represented by AC or AD
dimers, such that FAD binding would yield tetramers by
bringing the A protomer of AC together with the B protomer of
BD to yield ABCD tetramers. To determine which protomers
create the apo AidB dimers, we calculated s20,w values from the
crystal structure and compared them to the experimental s20,w
values for apo wtAidB and apo mtAidB. The excellent agreement
between the calculated value for the AB dimer (s20,w of 7.0 S) with
experiment (s20,w of 7.0 and 7.1 S) provides strong evidence that
deflavinated AidB has the form of an AB dimer. Thus, even though
the flavin cofactor appears to contribute stabilizing interactions to
the AB dimer, our data indicate that the AB dimer interface is
present even in the absence of bound flavin cofactor. In contrast,
the AC and AD interfaces are disintegrated upon deflavination
despite not being directly involved in flavin binding. Although an
unexpected result if one considers only direct FAD−protein
interactions, this result makes sense from the perspective of total
buried surface area. When a contact area is small, as is the case for
the AC and AD interfaces (1782 and 1319 Å2, respectively), even a
few changes in hydrogen bonds or packing interactions can make a
dramatic difference in interface stability, whereas when the interface
is extensive, such as the case with the AB dimer (6500 Å2),
hydrogen bonds and packing interactions can be lost without
having an impact on stability.
With a rationale at hand for why AidB is an AB dimer in the
absence of FAD, we then considered how FAD binding
generates AidB tetramers when the cofactor does not appear to
be directly involved in creating the tetramer interface. To more
carefully evaluate the tetramer interface, it was important to
obtain a crystal structure in which more than one protomer was
present in the asymmetric unit. In the P32 structure presented
here, the asymmetric unit contains three copies of the tetramer
interface, none of which are restrained by crystallographic
symmetry. With independent tetramers to analyze, we find that
binding of flavin to dimers of AidB could order residues that
create an intricate network of hydrogen bonds, thereby exerting
a long-range stabilization on the tetramer interface (Figure 6B).
Importantly, the L1′2′ loops (residues 69−80) that protrude
across the tetramer interface (Figure 4D) and make the
majority of contacts at the interface are involved in this
hydrogen bonding network. With so little buried surface area at
the tetramer interface, the loss or disruption of these
interactions due to the absence of FAD must be enough to
shift the balance from tetramer to dimer, while the AB interface
is strong enough to exist without FAD. Formation of the
tetramer interface could also be dependent on ionic strength, as
four chloride molecules are present at the interface, again
contacting the L1′2′ loop (Figure 6C). AidB remains a tetramer
at NaCl concentrations as low as 100 mM (data not shown),
but the instability of the protein precluded experiments at lower
salt concentrations.
Notably, while AidB shares sequence homology and
structural similarity with members of the ACAD family such
as IVD and medium chain acyl-CoA dehydrogenase
(MCAD),
16,43,44 the AidB L1′2′ loop and the DNA-binding
region are not conserved in any other members of the ACAD
family. Presumably, as a result of these differences, the
structures of IVD and MCAD reveal a completely different
tetrameric arrangement compared to that observed for AidB
(Figure S4 of the Supporting Information). The DNA-binding
domain prevents AidB from forming the IVD-type tetramer,
while the lack of the L1′2′ loop in IVD would restrict the
formation of an AidB-like tetramer in that protein. Thus, AidB
could have diverged from the ACAD family by the addition of
this DNA-binding domain, allowing it to perform its function in
the adaptive response, while the addition of the L1′2′ β-hairpin
loop would still allow for tetramer formation. With so few
alterations in the secondary structure between the ACAD
family and AidB, the adaptation of the L1′2′ loop suggests that
tetramerization is important to the function of AidB.
We also found that the transition from a tetrameric state to a
dimeric state is fully reversible and does not depend on the
flavin oxidation state, as reconstitution of apo wtAidB by
oxidized FAD restores the tetrameric state and reduced holo
wtAidB is a tetramer. Notably, incorporation of free FAD into
apo wtAidB is a highly cooperative process as indicated by both
AUC and fluorescence quenching studies. During stepwise
reconstitution experiments, regardless of the amount of FAD
used, all FAD-containing AidB molecules are tetramers.
Although we cannot predict the exact mechanism of
tetramerization, all of these results support a model in which
binding of substoichiometric amounts of FAD promotes
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structures of AidB protomers are likely to be retained during
deflavination, we observe a reversible and flavin-dependent
change in the oligomeric state, indicating that flavin, regardless
of oxidation state, does play a structural role in the creation of
the AidB tetramer.
Despite the switch in oligomeric state upon deflavination, the
in vitro DNA binding capability of apo AidB was not
significantly affected, with a <2-fold effect compared to that
of holo AidB. These results also suggest that tetramerization is
not essential for the interaction of AidB with double-stranded
DNA. In agreement with these findings, it was recently
reported that a truncated version of AidB that contains only the
DNA-binding domain, and thus is unlikely to be tetrameric,
retains the capability of binding DNA in vitro.
21 In vivo,
however, tetramerization could allow AidB to bind DNA at
multiple locations simultaneously.
Interestingly, the higher-order AidB oligomer observed in the
I222 crystal structure and proposed to sequester and thereby
protect DNA
20 is not present in the P32 crystal form, nor do we
observe any higher-order AidB oligomers in our solution
studies. The distinct architecture of the crystal lattice could be
due to the absence of DNA under our crystallization
conditions; however, no electron density for DNA was
observed in the previously reported structure.
20 More likely,
AidB can crystallize in multiple lattice systems, as is frequently
observed for other proteins (for examples, see refs 45 or 46 and
47), with these two AidB crystal structures representing two of
the possible lattice systems. While an AidB “mega complex”
exists at least in the I222 crystal lattice, a role for this complex
in sequestering DNA is not supported by our studies. With
respect to the idea of protection by DNA sequestration in
general, recent data from the Volkert laboratory oppose this
model.
17 Their data show that deletion of AidB’s DNA-binding
domain does not result in the loss of AidB’s protective function;
the protective ability is independent of DNA binding.
17
Protection in the absence of DNA binding is also inconsistent
with AidB serving as a DNA repair protein. While our studies
clearly show FAD-dependent oligomerization of AidB, they do
not address whether FAD also has a catalytic function.
However, the picture of AidB that is emerging invokes a role
for the DNA-binding domain in localization of AidB to specific
genes, while the protective function appears to reside elsewhere
on the protein.
17,21 Whether this protective function resides
with FAD or whether FAD was retained in the evolutionary
process solely for its ability to stabilize the AidB tetramer
remains to be determined.
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